Follow-The-Filings

Holders · period archive

URGN · Urogen Pharma Ltd

Q2 2026 13F holders among managers we track latest ownership dossier

Ticker
URGN
Type
Equity
Class
COM
Total reported value ($000, long equity)
Manager Report date Value Shares